LINC00511 and neoplasm: In addition, it was reported that rs11655237C>T in exon 4 of LINC00673 formed a target site for miR‐1231 binding, consequently restraining the LINC00673's tumor‐suppressing function and reducing the susceptibility of pancreatic cancer.6 Moreover, LINC00673 is also associated with the risk of non–small‐cell lung cancer (NSCLC), gastric cancer, breast cancer, hepatocellular cancer, tongue squamous cell carcinoma, and neuroblastoma.7, 8, 9, 10, 11, 12, 13, 14 In total, these results suggest that LINC00673 rs11655237C>T is implicated in a broad spectrum of tumors.